Some analysts say Eli Lilly's daily obesity pill, if approved, could still be a viable competitor in the weight loss drug market despite late-stage trial data that disappointed investors. In the trial ...

The number of abortions in the U.S. rose again in 2024, with women continuing to find ways to get them despite bans and restrictions in many states, according to a report out Monday. The latest report ...

The drugs in development include a pill that a new trial suggests is about as effective as Ozempic. By Dani Blum Reporting from the American Diabetes Association Scientific Sessions in Chicago.

Shares of Viking Therapeutics VKTX plunged 42% yesterday after it reported top-line data from the phase II VENTURE-Oral Dosing study, which evaluated the safety and efficacy of the oral formulation of ...